Ahana’s Story of Strength

Ahana’s Story of Strength with High-Risk Neuroblastoma

Every day, over 1,000 children worldwide are diagnosed with cancer,1 and for many families, that diagnosis means facing an uncertain future. At just 20 months old, Ahana was diagnosed with a rare and aggressive cancer that had already spread through her small body. Her family’s search for life-saving childhood cancer treatments led them from South Africa to Spain and possibly toward a clinical trial in New York. Ahana’s journey shows the importance of supporting organizations like Solving Kids’ Cancer, which works to find, fund, and advocate for advanced treatments that give hope to families fighting against tough-to-treat rare pediatric cancers.

A Devastating Diagnosis and a Family’s Determination

It all started when Ahana’s family first noticed a small lump on the back of their fun and energetic little girl. They took her to the doctor, hoping for a simple explanation.

A little boy wearing a pink shirt is smiling for the camera.

 Instead, they were told that a large tumor was pressing on her heart, lungs, and spinal cord, affecting her breathing and partially paralyzing her vocal cords. Her father, Aveen, recalls the moment clearly: “We were told that she had a large malignant tumor measuring 15cm in diameter. We were shattered.”

The diagnosis was stage 4 high-risk neuroblastoma, a rare pediatric cancer that affects around 700-800 children each year in the United States alone.2 Neuroblastoma is especially aggressive and difficult to treat, with only about a 50% survival rate for advanced cases because of the high risk of relapse, even after remission.3 Knowing Ahana would need the best possible childhood cancer treatment, her family made the difficult decision to relocate from South Africa to Spain, leaving behind their home and support network in hopes of giving her a better chance.4

A Setback in Spain: The Struggles of Childhood Cancer Treatment

When they arrived in Barcelona, Ahana’s medical team at Sant Joan de Déu Hospital (SJD) had hoped to remove her tumor through surgery. But within two weeks, new scans showed that the tumor had doubled in size, building up fluid in her lungs and making surgery impossible. Ahana’s doctors quickly turned to a specialized chemotherapy plan to control the cancer’s aggressive growth, and she began her first round, which included a targeted drug called Dasatinib.

However, just hours after starting treatment, Ahana’s body reacted severely. She lost consciousness, her oxygen levels dropped, and she was rushed to intensive care.

A man and a little girl pose in front of a sign that says sjd pediatric cancer center

Her mother, Avanya, recalls, “Life support was the only option.” The chemotherapy drug had caused heart damage, and doctors feared she had only hours left. Miraculously, Ahana’s body began to stabilize six hours later, and over the next few days, her heart function gradually improved.

Ahana’s struggle with the drug Dasatinib also shows the urgent need for treatments made just for children. Nearly two-thirds of childhood cancer survivors suffer long-term side effects from treatments designed for adults, which can harm their growing bodies.5 Child-focused cancer treatments are crucial to give young patients a healthier future without added health complications.

Ahana’s incredible recovery caught the attention of doctors from St. Jude Children’s Research Hospital in the United States. While visiting SJD, they asked if they could study her genetic data, hoping her case could help other children facing similar challenges. Her strength inspired everyone, giving her family renewed hope for the road ahead.

Progress After Surgery and a Race Against Time

With additional cycles of chemotherapy, coupled with the drug Lorlatinib to address a mutation they identified, Ahana’s tumor shrank by 50%, making surgery possible. A skilled team of doctors then performed a six-hour operation, successfully removing over 90% of the tumor. Showing incredible resilience, Ahana spent just one day in intensive care before going home four days later.

But even with this progress, Ahana’s journey is far from over. Neuroblastoma has one of the highest relapse rates of all childhood cancers. Even when remission is achieved, the cancer often comes back, leaving children with advanced cases, like Ahana’s, with only a 1 in 5 chance of surviving five years post-diagnosis, even with aggressive childhood cancer treatment.6 To reduce this risk, Ahana’s parents began researching options and found hope in a clinical trial at Memorial Sloan Kettering Cancer Center (MSK) in New York.7 This trial, which is the only one of its kind, is testing a cancer vaccine to prevent neuroblastoma from returning — a critical need for children like Ahana.

“Right now, this is our last and only option as it gives us hope for Ahana’s best chance of survival,” Avanya explains. “Time is of the essence as Ahana’s body is being ravaged by the progressing cancer.” Her family is now urgently raising funds to get her into the MSK trial, hoping to provide her with the most promising path to a full recovery.

A little girl is sitting on a ledge holding a drink.

The Power of Community Support

Ahana’s journey with high-risk neuroblastoma would not be possible without the support of a compassionate community. Friends, family, and even strangers have come together through GoFundMe and other platforms to help cover the high costs of treatment and travel. The Bluff Athletics Club in South Africa organized a 5km walk/run for Ahana, with over 400 people gathering to show their support and raise funds. “We are endlessly grateful for everyone who has helped us,” Avanya shared, deeply moved by the generosity that has kept them going.

Ahana’s story highlights how essential community support is for families facing childhood cancer. Childhood cancer statistics worldwide show that families with strong support networks are more likely to access the care they need, especially for rare and aggressive cancers. Solving Kids’ Cancer is dedicated to helping these families by funding research, connecting them with vital treatments, and advocating for solutions that give children like Ahana the best chance to fight.

The Mission of Solving Kids’ Cancer: Putting Kids First

At Solving Kids’ Cancer, our focus is simple: to make sure children with rare pediatric cancers get the attention and care they need. In a world where many needs compete, kids with rare cancers are sometimes left behind in the search for new treatments. We’re here to change that by funding important research and pushing for better treatments, giving real hope to families who need it most.

But our work isn’t just about funding studies. It’s about making sure children get faster access to new therapies, especially for tough cancers like high-risk neuroblastoma. This means helping kids receive treatments sooner, combating disparities that prevent access due to geography, and improving therapies like immunotherapy so they work better for young patients.

When you support Solving Kids’ Cancer, you’re helping families like Ahana’s gain access to life-saving clinical trials and treatments that can save lives. Together, we can make sure that every child has the chance to grow up healthy and strong.

A baby in a pink hoodie is holding a watermelon in the snow

Join Us in the Fight Against Childhood Cancer

Today, you can be part of Ahana’s story and support children around the globe who face similar battles. Every donation to Solving Kids’ Cancer fuels hope, funding the research and treatments that bring us closer to life-saving breakthroughs — because every kid deserves to grow up.

FUND A NEW TREATMENT TODAY!

Sources

1 World Health Organization: Childhood Cancer – International Childhood Cancer 2024: Reducing the Survival Gap
https://www.emro.who.int/media/news/international-childhood-cancer-day-2024-reducing-the-survival-gap.html
2 National Library of Medicine – Treatment and Survival of Childhood Neuroblastoma: Evidence from a Population-Based Study in the United States
https://pmc.ncbi.nlm.nih.gov/articles/PMC6764456/
3 MedicineNet – What Is the Life Expectancy of a Child with Neuroblastoma?
https://www.medicinenet.com/life_expectancy_of_a_child_with_neuroblastoma/article.htm
4 Southlands Sun News – Little Cancer Fighter Continues to Defy the Odds
https://www.citizen.co.za/southlands-sun/news-headlines/2024/10/16/little-cancer-fighter-continues-to-defy-the-odds/
5 National Library of Medicine – Late Effects of Childhood Cancer
https://www.ncbi.nlm.nih.gov/books/NBK221735/
6 National Library of Medicine – PCR-based amplification of circulating RNAs as prognostic and predictive biomarkers – Focus on neuroblastoma
https://pmc.ncbi.nlm.nih.gov/articles/PMC5575362/
7 Southlands Sun News – Help Bluff toddler receive international lifesaving cancer treatment
https://www.citizen.co.za/southlands-sun/news-headlines/local-news/2023/12/19/help-bluff-toddler-receive-international-lifesaving-cancer-treatment/
By Kristi McKay December 2, 2024
Ways to Give Back During the Holidays
A poster for 2024 year in review for solving kids ' cancer
November 11, 2024
Advancing Childhood Cancer Research: SKC’s 2024 Milestones
A group of children are holding a sign that says
October 1, 2024
Lace Up for Kids: Your Impact on Childhood Cancer Research At Solving Kids’ Cancer, our mission has always been driven by hope — hope for better treatments, hope for breakthroughs, and most importantly, hope for every child fighting cancer. This year’s Lace Up for Kids campaign was nothing short of inspiring. Together, we’ve raised over $264,000 across the entire campaign, funding innovative childhood cancer research and providing more treatment options for children in need.  From coast to coast, nearly 4,000 participants have stepped up to lace up their gold shoelaces and make a difference. Whether it was through schools, sports teams, or community groups, the show of support has been overwhelming throughout the years. Over 7,823 donations have been made to accelerate new treatments, and the hashtag #CareWearShare has been used 13,864 times, spreading the message far and wide!
A girl is standing in front of a car in a parking lot.
September 2, 2024
Gold Laces for Childhood Cancer Awareness Month: Erin’s Story 
A group of children are standing in a circle with their shoes on the floor.
August 8, 2024
Smithtown Goes Gold for Childhood Cancer Awareness Month!
A poster for lace up for kids with a butterfly on it
August 6, 2024
Childhood Cancer Awareness Month: Lace Up for Kids 2024
A man standing on top of a mountain with the words osteosarcoma survivor to surgeon dr. kurt weiss ' story
August 1, 2024
Osteosarcoma Survivor to Surgeon: Dr. Kurt Weiss’ Story
By Kristi McKay July 4, 2024
A Quick Guide to Your Role as a Parent Advocate 
Jacob 's journey : a childhood cancer survivor 's story
May 10, 2024
Jacob’s Journey: A Childhood Cancer Survivor’s Story Every battle has its heroes, and among the bravest are young children like Jacob Mozer, who faced stage 4 high-risk neuroblastoma when he was barely old enough to walk. Diagnosed at only 16 months old, Jacob’s early years were filled with constant medical appointments and intense treatments. Despite these challenges, today, Jacob is a shining example of the remarkable progress in pediatric oncology. He’s not merely surviving; he’s thriving as a pharmacy resident, driven to give back to the medical community that gave him a second chance at life. During National Cancer Survivors Month this June, we honor and celebrate fighters like Jacob who have battled cancer and emerged stronger. This month also serves to amplify the conversation about pediatric cancer survivorship and push for vital research that continues to save lives. Solving Kids’ Cancer (SKC) plays an essential role in this effort, supporting children like Jacob by funding crucial clinical trials that enhance survival rates and improve the quality of life for those fighting fatal childhood cancers.
A close up of a person holding a test tube in a laboratory.
May 2, 2024
Trailblazing Treatments for Pediatric Brain Tumors Picture a fortress built to guard precious treasure but accidentally also keeps out the very allies it needs in a time of crisis. This is the challenge faced by medical researchers when dealing with the brain’s natural defense — the blood-brain barrier — especially in children with brain tumors. At Columbia University Medical Center, Dr. Luca Szalontay is leading the charge to breach this fortress with groundbreaking approaches. Recently, Dr. Timothy Cripe from Solving Kids’ Cancer’s podcast, This Week in Pediatric Oncology (TWIPO) , interviewed Dr. Szalontay to delve deeper into these innovative treatments. This Brain Tumor Awareness Month, we’re shining a light on these important advances in treating children’s cancer. Understanding the Challenge Treating pediatric brain tumors like diffuse midline glioma (DMG) is especially tough because of the brain’s own protective shield, known as the blood-brain barrier. This barrier keeps out most chemotherapy drugs as well as large molecules, like antibodies, making it hard to treat the tumors effectively. Dr. Szalontay describes the dilemma: “Our field hasn’t been able to advance as quickly as it has with leukemias or other solid tumors because the drugs don’t penetrate the brain efficiently.” She adds on the nature of this blood-brain barrier, “It’s evolutionary, very important to protect us from different toxins and harmful agents, but this is a shield which protects the tumor as well.” Even when drugs work well in lab tests, they struggle to get to the tumor in strong enough doses without harming the body. Dr. Szalontay also points out that DMG tumors are found in very sensitive areas of the brain, making traditional surgery or radiation risky because they could damage vital brain functions. This makes finding safe and effective treatments for these tumors even more challenging. So, what’s being done to tackle these obstacles and help kids fight these tumors?
More Posts